Clinical outcomes of LASIK for myopia using the SCHWIND platform with ocular wavefront customized ablation.
To evaluate the clinical outcomes of aspheric ocular wavefront ablation profiles in LASIK treatments. Thirty eyes treated by ocular wavefront were retrospectively analyzed at 6-month follow-up. Custom Ablation Manager (CAM) software was used to plan wavefront-customized aspheric treatments, and the ESIRIS system was used to perform ablations (SCHWIND eye-tech-solutions). Outcomes were evaluated in terms of efficacy, predictability, refractive outcome, safety, and pre-and postoperative wavefront aberration analysis (SCHWIND Ocular Wavefront Analyzer). At 6 months postoperatively, 47% of eyes achieved uncorrected visual acuity 20/20 or better. Average defocus was reduced from -3.49+/-2.38 diopters (D) preoperatively (range: -10.63 to 0.00 D) to -0.14+/-0.31 D postoperatively (range: -1.75 to 0.00 D). Astigmatism was reduced from -0.81+/-1.15 D (range: -4.25 to 0.00 D) to -0.25+/-0.37 D (range: -1.25 to 0.00 D). Eighty-six percent of eyes were within +/- 0.50 D. Best spectacle-corrected visual acuity (logMAR) improved from +0.12+/-0.08 (range: 0.0 to +0.2) to -0.05+/-0.13 (range: -0.2 to +0.2) (P=.04). The treatment did not change coma or spherical aberration, and reduced the trefoil from 0.21+/-0.13 microm (range: 0.05 to 0.53 microm) to 0.08+/-0.13 microm (range: 0.01 to 0.39 microm) (P=.002). The study results indicate that the aspheric ocular wavefront customized CAM approach for planning ablation volumes is safe and effective.